« Previous
Next »
Maturitas
Volume 55
, Pages S37-S46
, 1 November 2006
The flavonoid apigenin inhibits the proliferation of prostatic stromal cells via the MAPK-pathway and cell-cycle arrest in G1/S
References
- . Benign prostatic hyperplasia. Lancet. 2003;361(9366):1359–1367
- . Hormone-induced morphogenesis and growth: role of mesenchymal–epithelial interactions. Recent Prog Horm Res. 1983;39:559–598
- . Changes in the prevalence of benign prostatic hyperplasia in China. Chin Med J (Engl). 1997;110(3):163–166
- Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr. 1991;54(6):1093–1100
- . Plasma concentrations of phyto-oestrogens in Japanese men. Lancet. 1993;342(8881):1209–1210
- . Phytoestrogens: potential endocrine disruptors in males. Toxicol Ind Health. 1998;14(1-2):223–237
- . Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. J Endocrinol. 1995;147(2):295–302
- Phytoestrogens and inhibition of angiogenesis. Baillieres Clin Endocrinol Metab. 1998;12(4):649–666
- . Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am J Clin Nutr. 1998;68(6 Suppl):1418S–1425S
- . Soy for breast cancer survivors: a critical review of the literature. J Nutr. 2001;131(11 Suppl):3095S–3108S
- . Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Yonsei Med J. 2002;43(2):236–241
- . Plant-derived phenolic antioxidants. Curr Opin Lipidol. 2000;11(1):43–47
- . The effect of cytokine mediators on prostaglandin inhibition by human decidual cells. Am J Obstet Gynecol. 1998;179(1):146–149
- . Cell-cycle arrest at G2/M and growth inhibition by apigenin in human colon carcinoma cell lines. Mol Carcinog. 2000;28(2):102–110
- Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer. 2000;87(4):595–600
- . Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res. 1990;50(3):499–502
- . Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells. Biochem Biophys Res Commun. 2001;287(4):914–920
- Screening for prostate cancer: updated experience from the Tyrol study. Curr Urol Rep. 2004;5:220–225
- . Modulation of the differentiation status of cultured prostatic smooth muscle cells by an alpha1-adrenergic receptor antagonist. Prostate. 1999;39(4):226–233
- . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254
- . Role of androgens in prostatic cancer. Vitam Horm. 1994;49:433–502
- . Estrogen receptor expression in developing epididymis, efferent ductules, and other male reproductive organs. Endocrinology. 1991;128(6):2874–2879
- . Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells. Oncogene. 2002;21(23):3727–3738
- . Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta. Eur Urol. 2004;45(2):245–251[discussion 251]
- Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139(10):4252–4263
- . Cell signaling and regulators of cell cycle as molecular targets for prostate cancer prevention by dietary agents. Biochem Pharmacol. 2000;60(8):1051–1059
PII: S0378-5122(06)00237-4
doi: 10.1016/j.maturitas.2006.06.015
© 2006 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Maturitas
Volume 55
, Pages S37-S46
, 1 November 2006
